Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Rund

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Leukemia & Lymphoma|April 25, 2007
Multidrug resistance in lymphoma: is it time for clinical trials?Deborah Rund
Leukemia & Lymphoma|October 7, 2011
Hepatitis B infection and myeloma in developing countries: therapeutic dilemmasDeborah Rund
British Journal of Haematology|November 8, 2021
A Paradigm shift in genotype-phenotype relationships in β-thalassaemiaDeborah Rund
Leukemia & Lymphoma|November 17, 2012
The elusive predisposing polymorphism: MDR1 and lymphomaDeborah Rund
Leukemia & Lymphoma|January 29, 2015
Bortezomib followed by autologous stem cell transplant for patients with hepatitis B positive multiple myeloma: a cautionary noteDeborah Rund
JAMA Network Open|November 12, 2021
Intravenous Iron and Infection Risk-Still an Unanswered QuestionDeborah Rund
Leukemia & Lymphoma|September 18, 2010
Multidrug resistance: overcoming the good, the bad, and the uglyDeborah Rund
Leukemia & Lymphoma|March 5, 2014
Targeting drug resistance to close the gap in diffuse large B-cell lymphomaDeborah Rund
Leukemia & Lymphoma|April 18, 2009
Multidrug resistance in myeloma: seeing the whole pictureDeborah Rund
British Journal of Haematology|February 5, 2019
Bittersweet news for the adult sickle cell patientDeborah Rund
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Leukemia & Lymphoma|April 25, 2007
Multidrug resistance in lymphoma: is it time for clinical trials?Deborah Rund
Leukemia & Lymphoma|October 7, 2011
Hepatitis B infection and myeloma in developing countries: therapeutic dilemmasDeborah Rund
British Journal of Haematology|November 8, 2021
A Paradigm shift in genotype-phenotype relationships in β-thalassaemiaDeborah Rund
Leukemia & Lymphoma|November 17, 2012
The elusive predisposing polymorphism: MDR1 and lymphomaDeborah Rund
Leukemia & Lymphoma|January 29, 2015
Bortezomib followed by autologous stem cell transplant for patients with hepatitis B positive multiple myeloma: a cautionary noteDeborah Rund
JAMA Network Open|November 12, 2021
Intravenous Iron and Infection Risk-Still an Unanswered QuestionDeborah Rund
Leukemia & Lymphoma|September 18, 2010
Multidrug resistance: overcoming the good, the bad, and the uglyDeborah Rund
Leukemia & Lymphoma|March 5, 2014
Targeting drug resistance to close the gap in diffuse large B-cell lymphomaDeborah Rund
Leukemia & Lymphoma|April 18, 2009
Multidrug resistance in myeloma: seeing the whole pictureDeborah Rund
British Journal of Haematology|February 5, 2019
Bittersweet news for the adult sickle cell patientDeborah Rund
Pageof 7